Haemonetics Corp.
HAE
Market Cap$4.24B
Close$
$106.02
26.8% upside
Current Fair Value
26.8% upsideUndervalued by 26.8% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $4.24 Billion |
|---|---|
| Enterprise Value | $4.92 Billion |
| Dividend Yield | $0.0 (0.0%) |
| Earnings per Share | $2.46 |
| Beta | 0.78 |
| Outstanding Shares | 50,786,117 |
| Avg 30 Day Volume | 412,215 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | 33.49 |
|---|---|
| PEG | -647.8 |
| Price to Sales | 3.34 |
| Price to Book Ratio | 4.65 |
| Enterprise Value to Revenue | 3.87 |
| Enterprise Value to EBIT | 27.21 |
| Enterprise Value to Net Income | 38 |
| Total Debt to Enterprise | 0.18 |
| Debt to Equity | 0.92 |
Revenue Sources
No data
ESG Score
No data
About Haemonetics Corp.
CEO: Christopher Simon